Skip to content

Maturation of Immunity Against Influenza

Maturation of Immunity Against Influenza - MIAI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034278
Enrollment
500
Registered
2024-06-04
Start date
2022-05-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection history of children within the first year of life with regard to family history, pregnancy & birth, living conditions, nutrition, etc.

Interventions

Group 1: Single arm observational study: Healthy term children (>37+0 gestational weeks) are followed over a period of one year and biosamples are obtained as well as data is collected. Time points st

Sponsors

Lehrstuhl für Translationale Pädiatrie - Kinderklinik am Universitätsklinikum Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Mature newborn (gestational age 37+0-41+6 gestational weeks) b) Place of residence of the family in the city or district of Würzburg c) Birth in the Department of Gynecology and Obstetrics of the University Hospital Würzburg

Exclusion criteria

Exclusion criteria: a) Congenital immunological or metabolic systemic diseases b) Severe congenital malformation c) Amniotic Infection Syndrome d) Neonatal sepsis in the first 72 hours of life e) In the next 12 months, change of residence outside the city or district of Würzburg

Design outcomes

Primary

MeasureTime frame
Primary objective: To investigate the postnatal transcriptional reprogramming of human respiratory and innate systemic immunity as a function of the composition and function of the gut microbiome.

Secondary

MeasureTime frame
Secondary objective a: Analysis of the relationship between the composition and function of the respiratory microbiome and the postnatal transcriptional reprogramming of human respiratory immunity. Secondary objective b: To determine the effect of perinatally released S100A8/A9 on the development of the respiratory and dermal microbiome.

Countries

Germany

Contacts

Public ContactDorothee;Carina Viemann;Hartmann

Lehrstuhl für Translationale Pädiatrie - Kinderklinik am Universitätsklinikum Würzburg;Lehrstuhl für Translationale Pädiatrie - Kinderklinik am Universitätsklinikum Würzburg

Viemann_D@ukw.de;Maier_C3@ukw.de0931-201 45848;0931-201 45851

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026